70 years, 70 voices: Dr. Nazende Günday-Türeli

Dr. Nazende Günday-Türeli

MyBiotech GmbH, CTO

“For me, the cooperation [...] means working together with amazing colleagues in a trusting and uncomplicated setting [...]“

Collaboration with innovation partner opens up new horizons

My first encounter with Fraunhofer IGB was in the context of the N2B-patch research project. Our goal was to develop an intranasal application platform for biopharmaceuticals as an innovative galenical formulation for the treatment of multiple sclerosis. Now we are joint partners in the Bio2Brain network, which runs a research and education program for training young scientists in the development of novel technologies with the aim of efficiently delivering biopharmaceuticals intranasally to the brain.

For me, the cooperation with Fraunhofer IGB means working together with amazing colleagues in a trusting and uncomplicated setting – that’s also highly professional. This is why Fraunhofer IGB is a reliable partner for us in applied innovation collaborations. Cooperative interdisciplinary work also enables us to fix our sights on joint partnerships in other R&D and innovation topics that we would not be able to tackle alone. As a result, it also offers opportunities for further projects that can lead to new horizons.

Günday Türeli

Ich wünsche dem Institut mit seinen zwei Institutsteilen weiterhin viel Erfolg und

Find out more about the N2B patch project and formulations.